These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23173713)

  • 1. The isotropic fractionator provides evidence for differential loss of hippocampal neurons in two mouse models of Alzheimer's disease.
    Brautigam H; Steele JW; Westaway D; Fraser PE; St George-Hyslop PH; Gandy S; Hof PR; Dickstein DL
    Mol Neurodegener; 2012 Nov; 7():58. PubMed ID: 23173713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
    Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
    Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model.
    Krantic S; Isorce N; Mechawar N; Davoli MA; Vignault E; Albuquerque M; Chabot JG; Moyse E; Chauvin JP; Aubert I; McLaurin J; Quirion R
    J Alzheimers Dis; 2012; 29(2):293-308. PubMed ID: 22232004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Spinal Cord Injury on Beta-Amyloid Plaque Pathology in TgCRND8 Mouse Model of Alzheimer's Disease.
    Yuan Q; Yang J; Xian YF; Liu R; Chan CW; Wu W; Lin ZX
    Curr Alzheimer Res; 2020; 17(6):576-586. PubMed ID: 32851942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model.
    Steele JW; Brautigam H; Short JA; Sowa A; Shi M; Yadav A; Weaver CM; Westaway D; Fraser PE; St George-Hyslop PH; Gandy S; Hof PR; Dickstein DL
    J Comp Neurol; 2014 Jul; 522(10):2319-35. PubMed ID: 24415002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease.
    Hamm V; Héraud C; Bott JB; Herbeaux K; Strittmatter C; Mathis C; Goutagny R
    Sci Adv; 2017 Feb; 3(2):e1601068. PubMed ID: 28275722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.
    Chung E; Ji Y; Sun Y; Kascsak RJ; Kascsak RB; Mehta PD; Strittmatter SM; Wisniewski T
    BMC Neurosci; 2010 Oct; 11():130. PubMed ID: 20946660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis.
    Verret L; Jankowsky JL; Xu GM; Borchelt DR; Rampon C
    J Neurosci; 2007 Jun; 27(25):6771-80. PubMed ID: 17581964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Ten eleven translocation-2 (Tet2) in modulating neuronal morphology and cognition in a mouse model of Alzheimer's disease.
    Li L; Miao M; Chen J; Liu Z; Li W; Qiu Y; Xu S; Wang Q
    J Neurochem; 2021 May; 157(4):993-1012. PubMed ID: 33165916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
    Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
    J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.
    Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T
    Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.